REGN
Price
$781.49
Change
-$11.77 (-1.48%)
Updated
Sep 11 closing price
Capitalization
80.46B
46 days until earnings call
Intraday BUY SELL Signals
THQ
Price
$18.92
Change
+$0.01 (+0.05%)
Updated
Sep 11 closing price
Net Assets
812.58M
Intraday BUY SELL Signals
Interact to see
Advertisement

REGN vs THQ

REGN vs THQ Comparison Chart in %
View a ticker or compare two or three
VS
REGN vs. THQ commentary
Sep 14, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is REGN is a Hold and THQ is a Hold.

Interact to see
Advertisement
SUMMARIES
Loading...
FUNDAMENTALS RATINGS
REGN: Fundamental Ratings
REGN
OUTLOOK RATING
1..100
50
VALUATION
overvalued / fair valued / undervalued
1..100
2
Undervalued
PROFIT vs RISK RATING
1..100
84
SMR RATING
1..100
59
PRICE GROWTH RATING
1..100
42
P/E GROWTH RATING
1..100
17
SEASONALITY SCORE
1..100
65

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
REGNTHQ
RSI
ODDS (%)
Bearish Trend 3 days ago
35%
Bearish Trend 3 days ago
77%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
68%
Bullish Trend 3 days ago
85%
Momentum
ODDS (%)
Bearish Trend 3 days ago
57%
Bearish Trend 3 days ago
77%
MACD
ODDS (%)
Bearish Trend 3 days ago
56%
Bearish Trend 3 days ago
79%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
56%
Bearish Trend 3 days ago
79%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
61%
Bearish Trend 3 days ago
78%
Advances
ODDS (%)
Bullish Trend 12 days ago
64%
Bullish Trend 11 days ago
84%
Declines
ODDS (%)
Bearish Trend 3 days ago
55%
Bearish Trend 4 days ago
85%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
46%
Bullish Trend 3 days ago
90%
Aroon
ODDS (%)
Bullish Trend 3 days ago
71%
Bullish Trend 3 days ago
85%
COMPARISON
Comparison
Sep 14, 2026
Stock price -- (REGN: $781.49)
Brand notoriety:
Market capitalization --

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

REGN’s FA Score shows that 2 FA rating(s) are green while .

  • REGN’s FA Score: 2 green, 3 red.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

REGN’s TA Score shows that 4 TA indicator(s) are bullish.

  • REGN’s TA Score: 4 bullish, 5 bearish.

Price Growth

REGN (@Biotechnology) experienced а -5.59% price change this weekfor the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -6.09%. For the same industry, the average monthly price growth was -3.45%, and the average quarterly price growth was +2531.70%.

Reported Earning Dates

REGN is expected to report earnings on Oct 29, 2026.

Industries' Descriptions

@Biotechnology (-6.09% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

View a ticker or compare two or three
REGN
Daily Signal:
Gain/Loss:
THQ
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
VYX8.550.48
+5.95%
NCR Voyix Corp
NOVT146.562.65
+1.84%
Novanta
ELV418.722.18
+0.52%
Elevance Health
DYNC10.90N/A
N/A
Dynamix Corporation
MODD2.54-0.10
-3.79%
Modular Medical Inc.

THQ and

Correlation & Price change

A.I.dvisor tells us that THQ and DHR have been poorly correlated (+13% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that THQ and DHR's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To THQ
1D Price
Change %
THQ100%
+0.05%
DHR - THQ
13%
Poorly correlated
-0.19%
ABBV - THQ
13%
Poorly correlated
+0.83%
UNH - THQ
10%
Poorly correlated
-2.37%
REGN - THQ
10%
Poorly correlated
-1.48%
MRK - THQ
9%
Poorly correlated
-0.54%
More